Literature DB >> 20338225

Ketamine impairs recognition memory consolidation and prevents learning-induced increase in hippocampal brain-derived neurotrophic factor levels.

B K Goulart1, M N M de Lima, C B de Farias, G K Reolon, V R Almeida, J Quevedo, F Kapczinski, N Schröder, R Roesler.   

Abstract

The non-competitive N-methyl-d-aspartate (NMDA) glutamate receptor antagonist ketamine has been shown to produce cognitive deficits. However, the effects of ketamine on the consolidation phase of memory remain poorly characterized. Here we show that systemic administration of ketamine immediately after training dose-dependently impairs long-term retention of memory for a novel object recognition (NOR) task in rats. Control experiments showed that the impairing effects of ketamine could not be attributed to an influence on memory retrieval or sensorimotor effects. In addition, ketamine prevented the increase in hippocampal brain-derived neurotrophic factor (BDNF) levels induced by NOR learning. Our results show for the first time that ketamine disrupts the consolidation phase of long-term recognition memory. In addition, the findings suggest that the amnestic effects of ketamine might be at least partially mediated by an influence on BDNF signaling in the hippocampus. Copyright 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20338225     DOI: 10.1016/j.neuroscience.2010.03.032

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  32 in total

1.  Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.

Authors:  Ji-Woon Kim; Lisa M Monteggia
Journal:  Behav Brain Res       Date:  2019-11-21       Impact factor: 3.332

2.  Serum brain-derived neurotrophic factor and nerve growth factor decreased in chronic ketamine abusers.

Authors:  Xiaoyin Ke; Yi Ding; Ke Xu; Hongbo He; Minling Zhang; Daping Wang; Xuefeng Deng; Xifan Zhang; Chao Zhou; Yuping Liu; Yuping Ning; Ni Fan
Journal:  Drug Alcohol Depend       Date:  2014-07-11       Impact factor: 4.492

3.  Proteolytic Degradation of Hippocampal STEP61 in LTP and Learning.

Authors:  Ana Saavedra; Jesús J Ballesteros; Shiraz Tyebji; Sara Martínez-Torres; Gloria Blázquez; Rosa López-Hidalgo; Garikoitz Azkona; Jordi Alberch; Eduardo D Martín; Esther Pérez-Navarro
Journal:  Mol Neurobiol       Date:  2018-06-12       Impact factor: 5.590

4.  Drugs of abuse as memory modulators: a study of cocaine in rats.

Authors:  Nabeel Rkieh; Jacob M Cloke; Nicola Gallagher; Boyer D Winters; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2013-12-13       Impact factor: 4.530

Review 5.  [Postoperative cognitive dysfunction. Possible neuronal mechanisms and practical consequences for clinical routine].

Authors:  R Haseneder; E Kochs; B Jungwirth
Journal:  Anaesthesist       Date:  2012-05       Impact factor: 1.041

6.  Strain and sex based characterization of behavioral expressions in non-induced compulsive-like mice.

Authors:  Swarup Mitra; Cristiane P Bastos; Savanna Chesworth; Cheryl Frye; Abel Bult-Ito
Journal:  Physiol Behav       Date:  2016-11-10

7.  Investigation of the Role of Stimulation and Blockade of 5-HT7 Receptors in Ketamine Anesthesia.

Authors:  Busra Dincer; Zekai Halici; Elif Cadirci
Journal:  J Mol Neurosci       Date:  2020-11-16       Impact factor: 3.444

8.  Protective effect of valproic acid in streptozotocin-induced sporadic Alzheimer's disease mouse model: possible involvement of the cholinergic system.

Authors:  Mirna Ezzat Sorial; Nesrine Salah El Dine El Sayed
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-10       Impact factor: 3.000

9.  GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice.

Authors:  Lakshmi Rajagopal; Jeffrey S Burgdorf; Joseph R Moskal; Herbert Y Meltzer
Journal:  Behav Brain Res       Date:  2015-11-26       Impact factor: 3.332

10.  GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.

Authors:  Jeffrey Burgdorf; Xiao-lei Zhang; Katherine L Nicholson; Robert L Balster; J David Leander; Patric K Stanton; Amanda L Gross; Roger A Kroes; Joseph R Moskal
Journal:  Neuropsychopharmacology       Date:  2012-12-05       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.